Everett, J ORCID: https://orcid.org/0000-0002-1864-9700, Brooks, J, Lermyte, F, O'Connor, PB, Sadler, PJ, Dobson, J, Collingwood, JF and Telling, ND ORCID: https://orcid.org/0000-0002-2683-5546 (2020) Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42). Scientific Reports, 10 (1).

[img]
Preview
Text
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42).pdf - Published Version
Available under License Creative Commons Attribution.

Download (8MB) | Preview

Abstract

Atypical low-oxidation-state iron phases in Alzheimer's disease (AD) pathology are implicated in disease pathogenesis, as they may promote elevated redox activity and convey toxicity. However, the origin of low-oxidation-state iron and the pathways responsible for its formation and evolution remain unresolved. Here we investigate the interaction of the AD peptide β-amyloid (Aβ) with the iron storage protein ferritin, to establish whether interactions between these two species are a potential source of low-oxidation-state iron in AD. Using X-ray spectromicroscopy and electron microscopy we found that the co-aggregation of Aβ and ferritin resulted in the conversion of ferritin's inert ferric core into more reactive low-oxidation-states. Such findings strongly implicate Aβ in the altered iron handling and increased oxidative stress observed in AD pathogenesis. These amyloid-associated iron phases have biomarker potential to assist with disease diagnosis and staging, and may act as targets for therapies designed to lower oxidative stress in AD tissue.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Uncontrolled Keywords: Alzheimer's disease; Dementia; Metals; Neurodegenerative diseases; Peptides
Subjects: Q Science > Q Science (General)
R Medicine > R Medicine (General)
Divisions: Faculty of Medicine and Health Sciences > School of Pharmacy and Bioengineering
Related URLs:
Depositing User: Symplectic
Date Deposited: 07 Jul 2020 14:16
Last Modified: 23 Jul 2020 09:38
URI: https://eprints.keele.ac.uk/id/eprint/8347

Actions (login required)

View Item View Item